drugset / Trial / NCT01459562
First in Human Study of an Anti-IFN Gamma Monoclonal Antibody in Healthy Volunteers
RandomizedSequentialTriple-blindBasic science
Summary
The purpose of this study is to determine the safety, pharmacodynamic and pharmacokinetic profiles of a novel therapeutic drug when administered to healthy volunteers.
Timeline
- Start
- 2011-09
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Emapalumab | Monoclonal antibody | — | Intravenous |
Indications
No indication recorded.